BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
BioRestorative Therapies, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$1.60+0.06 (+3.90%)
Close on Oct 19, 2026
- Market cap
- $28.36M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$30.10 (−94.95%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
BioRestorative Therapies, Inc. saw revenue fall 8.5% to $357.87K over the twelve months to Mar 31, 2026. Free cash flow was -$10.91M.
Revenue
$357.87K
-8.5% vs. a year earlier
Operating income
-$14.23M
TTM Q1 2026
Free cash flow
-$10.91M
FY2025
EPS, diluted
-$1.08
TTM Q1 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $28.36M
- P/E ratio
- –
- Price to sales
- 79.26
- Price to book
- 9.37
- Dividend yield
- –
- Free cash flow yield
- -38.45%
Fundamentals
- Revenue
- $357.87K
- Net income
- -$11.06M
- EPS, diluted
- -$1.08
- Free cash flow
- -$10.91M
- Book value per share
- $0.17
- Diluted shares
- 18M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$357.87K-8.5% YoY
Gross profit
$329.55K-8.5% YoY
Operating income
-$14.23M
Net income
-$11.06M
EPS, diluted
-$1.08
Free cash flow
–
Reported periodTrailing twelve months